0001104659-20-127314.txt : 20201221 0001104659-20-127314.hdr.sgml : 20201221 20201119155411 ACCESSION NUMBER: 0001104659-20-127314 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lifesci Acquisition II Corp. CENTRAL INDEX KEY: 0001819113 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 844278203 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 250 W 55TH ST. STREET 2: #3401 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 6468891200 MAIL ADDRESS: STREET 1: 250 W 55TH ST. STREET 2: #3401 CITY: NEW YORK STATE: NY ZIP: 10019 CORRESP 1 filename1.htm

LifeSci Acquisition II Corp.
250 W. 55th St., #3401
New York, New York 10019

November 19, 2020

VIA EDGAR & TELECOPY
Anuja A. Majmudar
Division of Corporation Finance

Office of Real Estate & Construction
U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549

RE:

LifeSci Acquisition II Corp. (the “Company”)
Registration Statement on Form S-1
(File No. 333-249480) (the “Registration Statement”)

Dear Ms. Majmudar:

The Company hereby requests, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, acceleration of effectiveness of the Registration Statement so that such Registration Statement will become effective as of 1:00 p.m. on November 20, 2020, or as soon thereafter as practicable.

The Company hereby acknowledges that:

Should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;

The action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and

The Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

[Signature page follows]

	Very truly yours,

	LIFESCI ACQUISITION II CORP.


	By:	/s/ Andrew McDonald
		Name: Andrew McDonald
		Title: Chief Executive Officer